GERN

$0.93+0.10%visit website

GERON CORP

Market Cap

$598M

Live price × SEC shares (Jul 31, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.61

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

2.7

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

N/M

TTM to Jun 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	47,227		51,837	57,480
Research & development	21,070	13,549	14,956	22,030	71,605
Selling, general & administrative	39,001	41,668	35,425	38,863	154,957
Total operating expenses	61,114	73,555	51,679	69,976	256,324
Operating income	(13,887)	(25,540)	158	(12,496)	(51,765)
Interest expense	8,644	7,297	7,147	7,146	30,234
Net income	(18,428)	(28,862)	(3,642)	(16,680)	(67,612)
EPS (basic) ($)	(0.03)		(0.01)	(0.02)	(0.11)
EPS (diluted) ($)	(0.03)		(0.01)	(0.02)	(0.11)
Weighted avg. shares (basic)	667,102		—	670,696
Weighted avg. shares (diluted)	667,102		—	670,696

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 5, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

9 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Oct 28, 2026 accepted 4:47 PM ET	8.01Other events	Document SEC ↗
Aug 6, 2026 accepted 6:05 AM ET	2.02Earnings release	Document SEC ↗
May 27, 2026 accepted 4:01 PM ET	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
Mar 26, 2026 accepted 8:18 AM ET	5.02Officer / director change	Document SEC ↗
Feb 25, 2026 accepted 7:15 AM ET	2.02Earnings release	Document SEC ↗
Jan 12, 2026 accepted 8:00 AM ET	7.01Reg FD disclosure	Document SEC ↗
Jan 6, 2026 accepted 6:01 AM ET	1.01Material agreement	Document SEC ↗
Dec 16, 2025 accepted 4:01 PM ET	2.05Restructuring costs	Document SEC ↗
Nov 5, 2025 accepted 7:06 AM ET	2.02Earnings release	Document SEC ↗
Oct 14, 2025 accepted 8:16 AM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗